期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 285, 期 12, 页码 8527-8536出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M109.055590
关键词
-
资金
- Swedish Brain Power
- Wallenberg Stiftelsen
- Loo och Hans Ostermans Stiftelse
- Magnus Bergvalls Stiftlelse
- Fonden for Alderforskning vid Karolinska Institutet
- Stiftelsen for Gamla Tjanarinnor
- Gun och Bertil Stohnes Stiftelse
gamma-Secretase is an enzyme complex that mediates both Notch signaling and beta-amyloid precursor protein (APP) processing, resulting in the generation of Notch intracellular domain, APP intracellular domain, and the amyloid beta peptide (A beta), the latter playing a central role in Alzheimer disease (AD). By a hitherto undefined mechanism, the activity of gamma-secretase gives rise to A beta peptides of different lengths, where A beta 42 is considered to play a particular role in AD. In this study we have examined the role of the large hydrophilic loop (amino acids 320-374, encoded by exon 10) of presenilin 1 (PS1), the catalytic subunit of gamma-secretase, for gamma-secretase complex formation and activity on Notch and APP processing. Deletion of exon 10 resulted in impaired PS1 endoproteolysis, gamma-secretase complex formation, and had a differential effect on A beta-peptide production. Although the production of A beta 38, A beta 39, and A beta 40 was severely impaired, the effect on A beta 42 was affected to a lesser extent, implying that the production of the AD-related A beta 42 peptide is separate from the production of the A beta 38, A beta 39, and A beta 40 peptides. Interestingly, formation of the intracellular domains of both APP and Notch was intact, implying a differential cleavage activity between the epsilon/S3 and gamma sites. The most C-terminal amino acids of the hydrophilic loop were important for regulating APP processing. In summary, the large hydrophilic loop of PS1 appears to differentially regulate the relative production of different A beta peptides without affecting Notch processing, two parameters of significance when considering gamma-secretase as a target for pharmaceutical intervention in AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据